Search Results : Diabetes

1155 interactions found:

Novel Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
claudin 7
Name2
epithelial cell adhesion molecule
Pathway 1
  • Tight junction interactions
Pathway 2
  • Cell surface interactions at the vascular wall
  • Attachment of bacteria to epithelial cells
  • Developmental Lineage of Mammary Gland Luminal Epithelial Cells
  • Developmental Lineage of Mammary Gland Alveolar Cells
  • Developmental Lineage of Mammary Gland Myoepithelial Cells
  • Developmental Lineage of Mammary Stem Cells
Drugs 1
Drugs 2
  • Oportuzumab monatox
  • ING-1
  • Catumaxomab
  • Technetium Tc-99m nofetumomab merpentan
  • Hypromellose
Diseases 1
Diseases 2
  • Mismatch repair deficiency, including: Hereditary non-polyposis colorectal cancer (HNPCC); Lynch syndrome; Muir-Torre syndrome; Turcot syndrome
Novel
Novel
Symbols
Name 1
homeobox A1
Name2
parathyroid hormone 1 receptor
Pathway 1
  • Activation of anterior HOX genes in hindbrain development during early embryogenesis
Pathway 2
  • Class B/2 (Secretin family receptors)
  • G alpha (s) signalling events
Drugs 1
Drugs 2
  • Abaloparatide
  • Parathyroid hormone
  • Teriparatide
Diseases 1
  • Bosley-Salih-Alorainy syndrome and Athabascan brainstem dysgenesis syndrome
Diseases 2
  • Eiken dysplasia
  • Blomstrand syndrome; Blomstrand chondrodysplasia
  • Primary failure of tooth eruption
  • Metaphyseal dysplasias, including: Metaphyseal dysplasia, Schmid type; Metaphyseal dysplasia, McKusik type; Metaphyseal dysplasia, Jansen type; Shwachman-Bodian-Diamond syndrome (SBDS); Metaphyseal anadysplasia (MAD)
Novel
Novel
Name 1
USH1 protein network component harmonin binding protein 1
Name2
coiled-coil domain containing 42
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
baculoviral IAP repeat containing 2
Name2
ubiquitin conjugating enzyme E2 Q2
Pathway 1
  • Apoptotic cleavage of cellular proteins
  • NOD1/2 Signaling Pathway
  • TICAM1, RIP1-mediated IKK complex recruitment
  • RIPK1-mediated regulated necrosis
  • TNFR1-induced proapoptotic signaling
  • Regulation of TNFR1 signaling
  • TNFR1-induced NF-kappa-B signaling pathway
  • TNFR2 non-canonical NF-kB pathway
  • Regulation of necroptotic cell death
  • TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
  • Ub-specific processing proteases
  • IKK complex recruitment mediated by RIP1
Pathway 2
  • Synthesis of active ubiquitin: roles of E1 and E2 enzymes
  • Antigen processing: Ubiquitination & Proteasome degradation
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
N-terminal glutamine amidase 1
Name2
tripartite motif containing 9
Pathway 1
Pathway 2
  • Antigen processing: Ubiquitination & Proteasome degradation
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
N-terminal glutamine amidase 1
Name2
acyl-CoA thioesterase 13
Pathway 1
Pathway 2
  • Mitochondrial Fatty Acid Beta-Oxidation
Drugs 1
Drugs 2
  • 2-Undecanone
Diseases 1
Diseases 2
Novel
Novel
Name 1
N-terminal glutamine amidase 1
Name2
glucosamine-6-phosphate deaminase 2
Pathway 1
Pathway 2
  • Glycolysis
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
syntaxin 8
Name2
natural killer cell cytotoxicity receptor 3 ligand 1
Pathway 1
Pathway 2
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
small glutamine rich tetratricopeptide repeat co-chaperone alpha
Name2
transmembrane protein 154
Pathway 1
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
SIN3-HDAC complex associated factor
Name2
GTP binding protein 3, mitochondrial
Pathway 1
Pathway 2
  • tRNA modification in the mitochondrion
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
transcriptional adaptor 2A
Name2
metaxin 2
Pathway 1
  • HATs acetylate histones
  • Formation of WDR5-containing histone-modifying complexes
Pathway 2
  • Mitochondrial protein import
  • Cristae formation
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
SRSF protein kinase 2
Name2
ADAM metallopeptidase with thrombospondin type 1 motif 18
Pathway 1
  • Maturation of nucleoprotein
Pathway 2
  • Degradation of the extracellular matrix
  • Defective B3GALTL causes PpS
  • O-glycosylation of TSR domain-containing proteins
Drugs 1
  • Adenine
  • Purvalanol
  • Phosphoaminophosphonic Acid-Adenylate Ester
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
SRSF protein kinase 2
Name2
chromodomain helicase DNA binding protein 1 like
Pathway 1
  • Maturation of nucleoprotein
Pathway 2
  • Formation of Incision Complex in GG-NER
  • Dual Incision in GG-NER
Drugs 1
  • Adenine
  • Purvalanol
  • Phosphoaminophosphonic Acid-Adenylate Ester
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
SRSF protein kinase 2
Name2
SEC16 homolog B, endoplasmic reticulum export factor
Pathway 1
  • Maturation of nucleoprotein
Pathway 2
  • COPII-mediated vesicle transport
Drugs 1
  • Adenine
  • Purvalanol
  • Phosphoaminophosphonic Acid-Adenylate Ester
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
SRSF protein kinase 2
Name2
YTH N6-methyladenosine RNA binding protein C2
Pathway 1
  • Maturation of nucleoprotein
Pathway 2
  • Nuclear RNA decay
Drugs 1
  • Adenine
  • Purvalanol
  • Phosphoaminophosphonic Acid-Adenylate Ester
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
actin gamma 1
Name2
ST3 beta-galactoside alpha-2,3-sialyltransferase 3
Pathway 1
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Gap junction degradation
  • Formation of annular gap junctions
  • Regulation of actin dynamics for phagocytic cup formation
  • Regulation of actin dynamics for phagocytic cup formation
  • EPHB-mediated forward signaling
  • EPH-ephrin mediated repulsion of cells
  • Adherens junctions interactions
  • Adherens junctions interactions
  • Recycling pathway of L1
  • Recycling pathway of L1
  • VEGFA-VEGFR2 Pathway
  • Interaction between L1 and Ankyrins
  • Interaction between L1 and Ankyrins
  • Cell-extracellular matrix interactions
  • RHO GTPases activate IQGAPs
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate Formins
  • RHO GTPases Activate Formins
  • MAP2K and MAPK activation
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF1 fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Clathrin-mediated endocytosis
  • RHOBTB2 GTPase cycle
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • Sensory processing of sound by inner hair cells of the cochlea
  • Sensory processing of sound by outer hair cells of the cochlea
  • FCGR3A-mediated phagocytosis
  • FCGR3A-mediated phagocytosis
  • Regulation of CDH1 Function
  • Formation of the dystrophin-glycoprotein complex (DGC)
  • Formation of the dystrophin-glycoprotein complex (DGC)
Pathway 2
  • Pre-NOTCH Processing in Golgi
  • Keratan sulfate biosynthesis
  • Defective ST3GAL3 causes MCT12 and EIEE15
  • Sialic acid metabolism
  • Lewis blood group biosynthesis
  • Maturation of protein 3a
  • Maturation of spike protein
  • Maturation of protein 3a
  • Termination of O-glycan biosynthesis
  • Glycosphingolipid biosynthesis
Drugs 1
  • Copper
  • Artenimol
Drugs 2
Diseases 1
Diseases 2
  • Nonsyndromic autosomal recessive mental retardation (NS-ARMR)
Novel
Novel
Name 1
protein tyrosine phosphatase non-receptor type 9
Name2
solute carrier family 16 member 13
Pathway 1
  • Interleukin-37 signaling
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
microtubule associated scaffold protein 2
Name2
zinc finger and BTB domain containing 38
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
emerin
Name2
C-type lectin domain containing 14A
Pathway 1
  • Nuclear Envelope Breakdown
  • Initiation of Nuclear Envelope (NE) Reformation
  • Depolymerization of the Nuclear Lamina
  • RAC1 GTPase cycle
  • RAC2 GTPase cycle
  • RHOD GTPase cycle
  • RHOG GTPase cycle
  • RAC3 GTPase cycle
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
Pathway 2
Drugs 1
Drugs 2
  • Resveratrol
Diseases 1
  • Emery-Dreifuss muscular dystrophy
Diseases 2
Novel
Novel
Name 1
testis expressed 11
Name2
glutaredoxin and cysteine rich domain containing 1
Pathway 1
Pathway 2
  • Sensory processing of sound by inner hair cells of the cochlea
  • Sensory processing of sound by outer hair cells of the cochlea
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
claudin 7
Name2
epithelial cell adhesion molecule
Pathway 1
  • Tight junction interactions
Pathway 2
  • Cell surface interactions at the vascular wall
  • Attachment of bacteria to epithelial cells
  • Developmental Lineage of Mammary Gland Luminal Epithelial Cells
  • Developmental Lineage of Mammary Gland Alveolar Cells
  • Developmental Lineage of Mammary Gland Myoepithelial Cells
  • Developmental Lineage of Mammary Stem Cells
Drugs 1
Drugs 2
  • Oportuzumab monatox
  • ING-1
  • Catumaxomab
  • Technetium Tc-99m nofetumomab merpentan
  • Hypromellose
Diseases 1
Diseases 2
  • Mismatch repair deficiency, including: Hereditary non-polyposis colorectal cancer (HNPCC); Lynch syndrome; Muir-Torre syndrome; Turcot syndrome
Novel
Symbols
Name 1
homeobox A1
Name2
parathyroid hormone 1 receptor
Pathway 1
  • Activation of anterior HOX genes in hindbrain development during early embryogenesis
Pathway 2
  • Class B/2 (Secretin family receptors)
  • G alpha (s) signalling events
Drugs 1
Drugs 2
  • Abaloparatide
  • Parathyroid hormone
  • Teriparatide
Diseases 1
  • Bosley-Salih-Alorainy syndrome and Athabascan brainstem dysgenesis syndrome
Diseases 2
  • Eiken dysplasia
  • Blomstrand syndrome; Blomstrand chondrodysplasia
  • Primary failure of tooth eruption
  • Metaphyseal dysplasias, including: Metaphyseal dysplasia, Schmid type; Metaphyseal dysplasia, McKusik type; Metaphyseal dysplasia, Jansen type; Shwachman-Bodian-Diamond syndrome (SBDS); Metaphyseal anadysplasia (MAD)
Novel
Name 1
USH1 protein network component harmonin binding protein 1
Name2
coiled-coil domain containing 42
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
baculoviral IAP repeat containing 2
Name2
ubiquitin conjugating enzyme E2 Q2
Pathway 1
  • Apoptotic cleavage of cellular proteins
  • NOD1/2 Signaling Pathway
  • TICAM1, RIP1-mediated IKK complex recruitment
  • RIPK1-mediated regulated necrosis
  • TNFR1-induced proapoptotic signaling
  • Regulation of TNFR1 signaling
  • TNFR1-induced NF-kappa-B signaling pathway
  • TNFR2 non-canonical NF-kB pathway
  • Regulation of necroptotic cell death
  • TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
  • Ub-specific processing proteases
  • IKK complex recruitment mediated by RIP1
Pathway 2
  • Synthesis of active ubiquitin: roles of E1 and E2 enzymes
  • Antigen processing: Ubiquitination & Proteasome degradation
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
N-terminal glutamine amidase 1
Name2
tripartite motif containing 9
Pathway 1
Pathway 2
  • Antigen processing: Ubiquitination & Proteasome degradation
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
N-terminal glutamine amidase 1
Name2
acyl-CoA thioesterase 13
Pathway 1
Pathway 2
  • Mitochondrial Fatty Acid Beta-Oxidation
Drugs 1
Drugs 2
  • 2-Undecanone
Diseases 1
Diseases 2
Novel
Name 1
N-terminal glutamine amidase 1
Name2
glucosamine-6-phosphate deaminase 2
Pathway 1
Pathway 2
  • Glycolysis
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
syntaxin 8
Name2
natural killer cell cytotoxicity receptor 3 ligand 1
Pathway 1
Pathway 2
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
small glutamine rich tetratricopeptide repeat co-chaperone alpha
Name2
transmembrane protein 154
Pathway 1
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
SIN3-HDAC complex associated factor
Name2
GTP binding protein 3, mitochondrial
Pathway 1
Pathway 2
  • tRNA modification in the mitochondrion
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
transcriptional adaptor 2A
Name2
metaxin 2
Pathway 1
  • HATs acetylate histones
  • Formation of WDR5-containing histone-modifying complexes
Pathway 2
  • Mitochondrial protein import
  • Cristae formation
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
SRSF protein kinase 2
Name2
ADAM metallopeptidase with thrombospondin type 1 motif 18
Pathway 1
  • Maturation of nucleoprotein
Pathway 2
  • Degradation of the extracellular matrix
  • Defective B3GALTL causes PpS
  • O-glycosylation of TSR domain-containing proteins
Drugs 1
  • Adenine
  • Purvalanol
  • Phosphoaminophosphonic Acid-Adenylate Ester
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
SRSF protein kinase 2
Name2
chromodomain helicase DNA binding protein 1 like
Pathway 1
  • Maturation of nucleoprotein
Pathway 2
  • Formation of Incision Complex in GG-NER
  • Dual Incision in GG-NER
Drugs 1
  • Adenine
  • Purvalanol
  • Phosphoaminophosphonic Acid-Adenylate Ester
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
SRSF protein kinase 2
Name2
SEC16 homolog B, endoplasmic reticulum export factor
Pathway 1
  • Maturation of nucleoprotein
Pathway 2
  • COPII-mediated vesicle transport
Drugs 1
  • Adenine
  • Purvalanol
  • Phosphoaminophosphonic Acid-Adenylate Ester
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
SRSF protein kinase 2
Name2
YTH N6-methyladenosine RNA binding protein C2
Pathway 1
  • Maturation of nucleoprotein
Pathway 2
  • Nuclear RNA decay
Drugs 1
  • Adenine
  • Purvalanol
  • Phosphoaminophosphonic Acid-Adenylate Ester
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
actin gamma 1
Name2
ST3 beta-galactoside alpha-2,3-sialyltransferase 3
Pathway 1
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Gap junction degradation
  • Formation of annular gap junctions
  • Regulation of actin dynamics for phagocytic cup formation
  • Regulation of actin dynamics for phagocytic cup formation
  • EPHB-mediated forward signaling
  • EPH-ephrin mediated repulsion of cells
  • Adherens junctions interactions
  • Adherens junctions interactions
  • Recycling pathway of L1
  • Recycling pathway of L1
  • VEGFA-VEGFR2 Pathway
  • Interaction between L1 and Ankyrins
  • Interaction between L1 and Ankyrins
  • Cell-extracellular matrix interactions
  • RHO GTPases activate IQGAPs
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate Formins
  • RHO GTPases Activate Formins
  • MAP2K and MAPK activation
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF1 fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Clathrin-mediated endocytosis
  • RHOBTB2 GTPase cycle
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • Sensory processing of sound by inner hair cells of the cochlea
  • Sensory processing of sound by outer hair cells of the cochlea
  • FCGR3A-mediated phagocytosis
  • FCGR3A-mediated phagocytosis
  • Regulation of CDH1 Function
  • Formation of the dystrophin-glycoprotein complex (DGC)
  • Formation of the dystrophin-glycoprotein complex (DGC)
Pathway 2
  • Pre-NOTCH Processing in Golgi
  • Keratan sulfate biosynthesis
  • Defective ST3GAL3 causes MCT12 and EIEE15
  • Sialic acid metabolism
  • Lewis blood group biosynthesis
  • Maturation of protein 3a
  • Maturation of spike protein
  • Maturation of protein 3a
  • Termination of O-glycan biosynthesis
  • Glycosphingolipid biosynthesis
Drugs 1
  • Copper
  • Artenimol
Drugs 2
Diseases 1
Diseases 2
  • Nonsyndromic autosomal recessive mental retardation (NS-ARMR)
Novel
Name 1
protein tyrosine phosphatase non-receptor type 9
Name2
solute carrier family 16 member 13
Pathway 1
  • Interleukin-37 signaling
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
microtubule associated scaffold protein 2
Name2
zinc finger and BTB domain containing 38
Pathway 1
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
emerin
Name2
C-type lectin domain containing 14A
Pathway 1
  • Nuclear Envelope Breakdown
  • Initiation of Nuclear Envelope (NE) Reformation
  • Depolymerization of the Nuclear Lamina
  • RAC1 GTPase cycle
  • RAC2 GTPase cycle
  • RHOD GTPase cycle
  • RHOG GTPase cycle
  • RAC3 GTPase cycle
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
Pathway 2
Drugs 1
Drugs 2
  • Resveratrol
Diseases 1
  • Emery-Dreifuss muscular dystrophy
Diseases 2
Novel
Name 1
testis expressed 11
Name2
glutaredoxin and cysteine rich domain containing 1
Pathway 1
Pathway 2
  • Sensory processing of sound by inner hair cells of the cochlea
  • Sensory processing of sound by outer hair cells of the cochlea
Drugs 1
Drugs 2
Diseases 1
Diseases 2

Page 42 out of 58 pages

© Madhavi K. Ganapathiraju 2012-2025